$7.28
3.85% today
Nasdaq, Feb 28, 03:30 pm CET
ISIN
US74019L1070
Symbol
PRPO
Sector
Industry

Precipio, Inc. Stock price

$7.57
+1.10 17.04% 1M
+1.33 21.34% 6M
+2.03 36.68% YTD
+1.07 16.49% 1Y
-23.03 75.26% 3Y
-20.03 72.57% 5Y
-15,652.43 99.95% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+0.61 8.79%
ISIN
US74019L1070
Symbol
PRPO
Sector
Industry

Key metrics

Market capitalization $11.22m
Enterprise Value $11.45m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 0.66
P/S ratio (TTM) P/S ratio 0.64
P/B ratio (TTM) P/B ratio 0.94
Revenue growth (TTM) Revenue growth 31.31%
Revenue (TTM) Revenue $17.41m
EBIT (operating result TTM) EBIT $-4.73m
Free Cash Flow (TTM) Free Cash Flow $-240.00k
Cash position $1.05m
EPS (TTM) EPS $-2.06
P/E forward 3.61
P/S forward 0.37
EV/Sales forward 0.35
Short interest 0.35%
Show more

Is Precipio, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Precipio, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Precipio, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Precipio, Inc.:

Buy
100%

Financial data from Precipio, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
17 17
31% 31%
100%
- Direct Costs 11 11
27% 27%
66%
5.96 5.96
41% 41%
34%
- Selling and Administrative Expenses 9.24 9.24
22% 22%
53%
- Research and Development Expense - -
-
-
-3.28 -3.28
57% 57%
-19%
- Depreciation and Amortization 1.45 1.45
5% 5%
8%
EBIT (Operating Income) EBIT -4.73 -4.73
48% 48%
-27%
Net Profit -3 -3
67% 67%
-17%

In millions USD.

Don't miss a Thing! We will send you all news about Precipio, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Precipio, Inc. Stock News

Neutral
GlobeNewsWire
3 days ago
Both metrics demonstrate the ability to achieve financial independence Both metrics demonstrate the ability to achieve financial independence
Neutral
GlobeNewsWire
about one month ago
NEW HAVEN, Conn., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company  Precipio, Inc.   (NASDAQ: PRPO) , announced that options granted to senior management on January 14 would vest when the 10-day VWAP of the Company's common stock exceeds $30.30 per share – a level 5x greater than the option exercise price, the closing price from Tuesday, January 14.
Neutral
Seeking Alpha
3 months ago
Precipio, Inc. (NASDAQ:PRPO ) Q3 2024 Earnings Conference Call November 18, 2024 5:00 PM ET Company Participants Ilan Danieli - CEO Conference Call Participants Operator Good day. Welcome to the Precipio Third Quarter 2024 Shareholder Update Conference Call.
More Precipio, Inc. News

Company Profile

Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Head office United States
CEO Ilan Danieli
Employees 57
Founded 1997
Website www.precipiodx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today